%0 Generic
%A Ciruelos, E. M.
%A Garcia, A. A.
%A Cortes, J.
%A Pernas Simon, S.
%A Garate, E.
%A Mele, M.
%A Montano, A.
%A Martinez-Janez, N.
%A Oliveira, M.
%A de la Haba-Rodriguez, J.
%A Vega, E.
%A Perello Martorell, A.
%A Bermejo De Las Heras, B.
%A Cantos Sanchez De Ibarguen, B.
%A Martinez, E.
%A Vila Navarro, E.
%A Pascual, T.
%A Gonzalez-Farre, X.
%A Villagrasa, P.
%A Prat, A.
%T SOLTI-1303 PATRICIA 2 randomized phase II trial of palbociclib plus trastuzumab and endocrine therapy (ET) versus treatment of physician's choice (TPC) in metastatic HER2-positive and hormone receptor-positive (HER2+/HR+) breast cancer (BC) with PAM50 luminal intrinsic subtype
%D 2021
%@ 0923-7534
%U https://hdl.handle.net/10668/25898
%~